Ranedis Pharmaceuticals


At RaNeDis Pharmaceuticals we are focused on the treatment and management of rare and neglected diseases.  RaNeDis Pharmaceuticals is a development stage pharmaceutical company engaged in the development of a novel formulation of an HDAC inhibitor with enhanced brain exposure for the treatment of rare genetic, metabolic diseases.
RaNeDis Pharmaceuticals’ technology was licensed from the University of Notre Dame.